Ipf and drugs of ingredients of simvastatin (a real world drug study)
Summary:
Ipf is found among people who take drugs with ingredients of simvastatin, especially for people who are male, 60+ old , have been taking the drugs for 2 - 5 years. This phase IV clinical study is created by eHealthMe based on reports of 330,452 people who have side effects when taking drugs with ingredients of simvastatin from the FDA, and is updated regularly.
Drug(s) considered in the study (i.e. both brand name and generic drugs): Flolipid, Simvastatin, Zocor.
330,452 people reported to have side effects when taking drugs with ingredients of simvastatin.
Among them, 1,160 people (0.35%) have Ipf
What is Ipf?
Ipf is found to be associated with 2,135 drugs and 2,253 conditions by eHealthMe. Check the latest studies of Ipf.
Number of reports submitted per year:

Time on drugs with ingredients of simvastatin when people have Ipf *:
- < 1 month: 8.28 %
- 1 - 6 months: 3.45 %
- 6 - 12 months: 11.03 %
- 1 - 2 years: 11.72 %
- 2 - 5 years: 33.1 %
- 5 - 10 years: 24.83 %
- 10+ years: 7.59 %
Gender of people who have Ipf when taking drugs with ingredients of simvastatin *:
- female: 41.18 %
- male: 58.82 %
Age of people who have Ipf when taking drugs with ingredients of simvastatin *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.1 %
- 20-29: 0.1 %
- 30-39: 0.0 %
- 40-49: 4.11 %
- 50-59: 10.17 %
- 60+: 85.51 %
Conditions people have *:
You may use this to check any potential undetected conditions.
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 204 people, 17.59%
- Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 73 people, 6.29%
- Gastric Disorder (disease of stomach): 69 people, 5.95%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 51 people, 4.40%
- Diabetes: 31 people, 2.67%
- Psoriasis (immune-mediated disease that affects the skin): 29 people, 2.50%
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 27 people, 2.33%
- Hyperlipidaemia (presence of excess lipids in the blood): 27 people, 2.33%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 27 people, 2.33%
- Depression: 23 people, 1.98%
Other drugs people take *:
You may use this to check any potential interacting drugs.
- Aspirin: 201 people, 17.33%
- Prednisone: 169 people, 14.57%
- Folic Acid: 166 people, 14.31%
- Metformin: 166 people, 14.31%
- Humira: 158 people, 13.62%
- Methotrexate: 149 people, 12.84%
- Atenolol: 145 people, 12.50%
- Celebrex: 134 people, 11.55%
- Ramipril: 130 people, 11.21%
- Fosamax: 128 people, 11.03%
Other side effects people have besides Ipf *:
You may use this to check any potential undetected side effects.
- Pneumonia: 299 people, 25.78%
- Dyspnea (difficult or laboured breathing): 245 people, 21.12%
- Pain: 209 people, 18.02%
- Cough: 165 people, 14.22%
- Joint Pain: 164 people, 14.14%
- Fatigue (feeling of tiredness): 144 people, 12.41%
- Rashes (redness): 139 people, 11.98%
- Interstitial Lung Disease: 139 people, 11.98%
- Drug Ineffective: 138 people, 11.90%
- Headache (pain in head): 131 people, 11.29%
* Approximation only. Some reports may have incomplete information.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Drugs with ingredients of simvastatin, their effectiveness, alternatives and more:
How the study uses the data?
The study uses data from the FDA. It is based on simvastatin. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Methimazole and Lamotrigine - a second ago
- Could Augmentin '125' cause Duodenal Ulcer Aggravated? - a second ago
- Sertraline and Gastritis Aggravated for Women aged 60+ - 10 seconds ago
- Could Soma cause Rash Erythematous Aggravated? - 11 seconds ago
- Could Benicar cause Anorexia? - 16 seconds ago
- Etoposide and Insomnia Exacerbated for Men aged 60+ - 23 seconds ago
- Tysabri and Methotrexate drug interactions for women aged 40-49 - 27 seconds ago
- Could Gilenya cause Hepatotoxicity Aggravated? - 27 seconds ago
- Drug interactions of Depakote and Ibuprofen - 36 seconds ago
- Drug interactions of Sumatriptan and Nizoral - 41 seconds ago